Public information on osteoporosis
Article Abstract:
The Congressional Office of Technology Assessment (OTA) has prepared a report on the availability and sources of information on osteoporosis. The report identifies three major source: mass media, private organizations and government agencies. The mass media's tendancy to oversimplify research findings and not follow up on medical news make the information it provides less than reliable. The National Osteoporosis Foundation, a private non-profit organization, may be the best source of information on osteoporosis. The Depts of Health and Human Services and Agriculture each offer information, as do some state governments. The National Resource Center on Osteoporosis and Related Bone Diseases, established in 1993, has recently opened and will focus its attention on providing information about FDA approval of drugs and the risks of osteoporosis to men and minorities, who are underrepresented in other information sources.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Chronic Hyponatremic Encephalopathy in Postmenopausal Women: Association of Therapies With Morbidity and Mortality
Article Abstract:
Intravenous sodium chloride appears to be the best treatment for postmenopausal women with hyponatremia. Hyponatremia is the medical term for low blood levels of sodium. In a study of 53 postmenopausal women with hyponatremia, 14 were treated with fluid restriction, 22 with intravenous sodium chloride after they developed respiratory insufficiency, and 17 with intravenous sodium chloride before they developed respiratory insufficiency. Those treated with intravenous sodium chloride before they developed respiratory insufficiency had the best outcome and those treated with fluid restriction had the worst outcome. Eighty-three percent of the women died or developed serious illness.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial
Article Abstract:
The drug iprifiavone does not appear to prevent bone loss in postmenopausal women or prevent bone fractures in women with osteoporosis. Iprifiavone is a synthetic version of chemicals called isoflavones and is sold over-the-counter in the US under the trade name Ostovone.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. Adverse events, including death, associated with the use of 1,4-butanediol
- Abstracts: Saving the Vision of Children With Juvenile Rheumatoid Arthritis-Associated Uveitis. Prospects for Autoimmune Disease - Research Advances in Rheumatoid Arthritis
- Abstracts: Firing lines: automatic fire doors. Fire safety in the future. Fire extinguishers use survey
- Abstracts: Infant mortality as a social mirror. Prolongation of the QT interval and the sudden infant death syndrome
- Abstracts: Healthy weight: a process of changing your lifestyle habits. Habits: a little know-how can turn '92 resolutions into reality